Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1991-08-16
1993-07-20
Lee, Lester L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 19, 514400, 530330, 530331, 5483381, A61K 3702, C07K 506, C07K 508, C07K 510
Patent
active
052293696
ABSTRACT:
Non-peptidyl compounds characterized generally as aminoalkylaminocarbonyl aminodiol derivatives of amino acids are useful as renin inhibitors for the treatment of hypertension. Compounds of particular interest are of the formula ##STR1## wherein X is selected from oxygen atom and methylene; wherein each of R.sub.1 and R.sub.9 is independently selected from hydrido, methyl, ethyl, t-butyloxycarbonyl; and methoxymethylcarbonyl; wherein R.sub.2 is selected from hydrido, methyl, ethyl and isopropyl; wherein R.sub.3 is selected from benzyl, phenethyl, pyridylmethyl and 2-pyridylethyl; wherein each of R.sub.4 and R.sub.6 is independently selected from hydrido and methyl; wherein R.sub.7 is cyclohexylmethyl; wherein R.sub.8 is isobutyl; wherein each of R.sub.11 and R.sub.12 is hydrido; wherein m is zero or one and n is a number selected from zero through five; or a pharmaceutically-acceptable salt thereof; with the proviso that where m is zero, then R.sub.5 is selected from imidazolemethyl, thiazolemethyl and isobutyl; and with the further proviso that when m is one, then R.sub.5 is methyl or ethyl.
REFERENCES:
patent: 4845079 (1989-07-01), Luly et al.
patent: 4902706 (1990-02-01), Hanson et al.
Burger, Medicinal Chemistry, 1960, pp. 565-571, 578-581, 600-601.
Derkewalker et al; Progress for Drug Research, 1965, col. 10, pp. 510-512.
Haber et al, J. Cardiovasc. Pharm., 1987, 10 (Supp. 7) pp. 554-558.
Plattner et al., J. Med. Chem., 1987, 31(12) 2277-2288.
Umezawa et al, in J. Antibiot. (Tokyo), 23, 259-262 (1970).
Gross et al, Science, 175, 656 (1971).
Boger et al, Nature, 303, 81 (1983).
Kokubu et al, Biochm. Biophys. Res. Commun., 118, 929 (1984).
Castro et al, FEBS Lett., 167, 273 (1984).
Hanson et al, Biochm. Biophys. Res. Comm., 132, 155-161 (1985), 146, 959-963 (1987).
Marshall, Federation Proc., 35, 2494-2501 (1976).
Burton et al, Proc. Natl. Acad. Sci. USA, 77, 5476-5479 (1980).
Suketa et al, Biochemistry, 14, 3188 (1975).
Swales, Pharmac. Ther., 7, 173-201 (1979).
Kokubu et al, Nature, 217 456-457 (1968).
Matsushita et al, J. Antibiotics, 28, 1016-1018 (1975).
Lazar et al, Biochem. Pharma., 23, 2776-2778 (1974).
Miller et al., Biochem. Pharma., 21, 2941-2944 (1972).
Haber, Clinical Science, 59 7s-19s (1980).
Rich et al, J. Org. Chem., 43, 3624 (1978).
Rich et al, J. Med. Chem., 23, 27 (1980).
Haber, Clin. and Exper. Hyper., A5(7 & 8), 1193 (1983).
Baran John S.
Hanson Gunnar J.
G. D. Searle & Co.
Keane J. Timothy
Lee Lester L.
Matukaitis Paul D.
LandOfFree
Aminoalkylaminocarbonyl aminodiol amino acid derivatives as anti does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aminoalkylaminocarbonyl aminodiol amino acid derivatives as anti, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aminoalkylaminocarbonyl aminodiol amino acid derivatives as anti will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1760539